Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
American Health & Drug Benefits|April 12, 2016
The Economics of Medicare Accountable Care OrganizationsErwin A Blackstone, Joseph P FuhrJournal of Health Care Finance|November 1, 2008
Specialty hospitals: the economics and policy issues they poseErwin A Blackstone, Joseph P FuhrBiotechnology Healthcare|May 19, 2012
Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safetyErwin A Blackstone, Joseph P FuhrFuture Medicinal Chemistry|March 25, 2011
Biosimilars and innovation: an analysis of the possibility of increased competition in biopharmaceuticalsErwin A Blackstone, Joseph P FuhrBiotechnology Healthcare|February 12, 2013
Generic biopharmaceutical drugs: an economic and policy analysisErwin A Blackstone, Joseph P FuhrBiotechnology Healthcare|April 6, 2012
Biopharmaceuticals: the economic equationErwin A Blackstone, Joseph P FuhrAmerican Health & Drug Benefits|August 16, 2014
The health and economic effects of counterfeit drugsErwin A Blackstone, Joseph P Fuhr, Steve PociaskBiotechnology Healthcare|October 24, 2012
Will comparative effectiveness research finally succeed?Erwin A Blackstone, Joseph P Fuhr, Danielle ZiernickiExpert Review of Pharmacoeconomics & Outcomes Research|May 1, 2009
Biosimilars and follow-on biologicsJoseph P FuhrPageof 2